For example, various TPM1 and TPM2 mutations have been implicated in hypertrophic cardiomyopathy (HCM) including familial hypertrophic cardiomyopathy (FHC) in humans [31]. Here, TPM2 is linked to familial hypertrophic cardiomyopathy.